US2001044533A1PendingUtilityA1
Purification process
Priority: Aug 14, 1995Filed: Jun 13, 2001Published: Nov 22, 2001
Est. expiryAug 14, 2015(expired)· nominal 20-yr term from priority
A61P 31/00C07D 501/00A61P 31/04
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Processes for the depletion of 7-ADCA in mixtures of vinyl-ACA with 7-ADCA via novel salts of vinyl-ACA or via chromatography.
Claims
exact text as granted — not AI-modified1 . A process for the depletion of 7-ADCA of formula
in a mixture of 7-ADCA and vinyl-ACA of formula
2 . A process according to claim 1 , wherein
a) a mixture of a salt of a compound of formula I and a compound of formula II is subjected to crystallization, the crystallised salt is isolated and converted into a compound of formula I, containing less compound of formula II than the mixture of a compound of formula I and formula II, or b) a mixture of a compound of formula I and a compound of formula II is subjected to chromatography.
3 . A process according to claim 2 , wherein a mixture of a salt of a compound of formula I and a compound of formula II is a mixture of compounds of formulae
wherein X + denotes a cation, or a compound of formula
wherein
R 1 , R 2 and R 3 are the same or different and independently of one another denote hydrogen, alkyl, aryl, aralkyl, or cycloalkyl; or
R 1 and R 2 together with the nitrogen atom form a heterocycle and R 3 is as defined above.
4 . A process according to claim 2 , wherein a mixture of a salt of a compound of formula I and a compound of formula II is produced by addition of a salt forming agent to a mixture of a compound of formula I as defined in claim 1 and a compound of formula II as defined in claim 1 in a solvent.
5 . A process according to claim 4 , wherein the salt forming agent is an inorganic base, an inorganic salt, an organic salt or a nitrogen base.
6 . A process according to claim 5 , wherein the inorganic base is a hydroxide; the inorganic salt is an inorganic alkali salt; the organic salt is an alkali salt of a carboxylic acid; and the nitrogen base is a compound of formula
wherein R 1 , R 2 and R 3 are as defined in claim 3 .
7 . A compound of formula
wherein X + is as defined in claim 3 , in crystalline form.
8 . Dicyclohexylammonium salt of 7-amino-3-vinyl-cephalosporanic acid in crystalline form
Tert.octylammonium salt of 7-amino-3-vinyl-cephalosporanic acid in crystalline form N-Benzyl-tert.butylammonium salt of 7-amino -3-vinyl -cephalosporanic acid in crystalline form 2-Ethyl-1-hexylammonium salt of 7-amino-3-vinyl-cephalosporanic acid in crystalline form Potassium salt of 7-amino-3-vinyl-cephalosporanic acid in crystalline form.
9 . Use of a compound of formula
wherein X + is as defined in claim 3 , or the use of a process as defined in claim 1 , in the production of highly active cephalosporins.
10 . Depletion process of 7-ADCA of formula
in mixtures of vinyl-ACA of formula
with 7-ADCA, characterised in that
a) a mixture of vinyl-ACA and 7-ADCA is converted into salts of formula
wherein X ⊕ is Li ⊕ , Na ⊕ , K + or a cation of formula
wherein R 1 ′, R 2 ′ and R 3 ′ are the same or different and independently of one another denote hydrogen, (C 1-8 )alkyl, optionally substituted benzyl or phenyl or (C 4-8 )cycloalkyl, or R 1 ′ and R 2 ′ together with the nitrogen form a 5- or 6-membered heterocycle which optionally contains a further one or two hetero atoms, and R 3 ′ is as defined above,
by reaction of the mixture of vinyl-ACA and 7-ADCA with a lithium, sodium or potassium base or with an amine of formula
wherein R 1 ′, R 2 ′ and R 3 ′ are as defined above, whereby
α) the reaction is carried out in a solvent or solvent mixture in which the salts of formulae III and IV have different solubilities, or
β) the salts of the compounds of formulae III and IV are suspended in a solvent or solvent mixture, and the solubility product is adjusted,
and after isolating the compound of formula III, this is converted using an acid into the compound of formula I having no content or a reduced content of 7-ADCA, or
b) a solution of a mixture of vinyl-ACA with 7-ADCA is subjected to chromatography.Join the waitlist — get patent alerts
Track US2001044533A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.